No profile data available.
Synlogic, Inc. (SYBX) is a healthcare company in the autoimmune treatment pharmaceuticals industry, based in Winchester, United States, with about 1 full-time employees.
It reported revenue of $0 for fiscal year 2025, down 100.0% from fiscal year 2024, and net income of -$1.01 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $13.47 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Synlogic reported $0 in revenue for fiscal year 2025, down 100.0% from $8,000 in fiscal year 2024. In Q1 2026 revenue was $0.
$13.47 million as of October 9, 2026.
Listed companies of a similar size in the same industry (autoimmune treatment pharmaceuticals) include Adicet Bio, Inc. (ACET), Kezar Life Sciences, Inc. (KZR), Cue Biopharma, Inc. (CUE), FibroBiologics, Inc. (FBLG).